Fred Hutchinson Cancer Research Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center

1100 Fairview Ave. N.
P.O. Box 19024
Seattle, Washington, United States
Email   Phone   Web  
Fred Hutch is at the forefront of developing treatments for multiple myeloma. The researchers pioneered bone marrow transplantation, one of the most significant advances in treating myeloma, lymphoma and other blood cancers. Fred Hutch investigators continue to improve bone marrow and blood stem cell transplantation for myeloma, making these therapies safer and more effective. 
 
More than 300 scientists in five scientific divisions continually generate new discoveries and translate them into effective medical practices, therapeutic strategies and public health approaches. This cooperative approach is achieved through informal activities as well as through integrated research centers, institutions and networks. 
 
They also pioneered the mini-transplant, a gentler version of transplantation that reduces a patient’s radiation exposure to a minimal dose, and are bringing cutting-edge immunotherapy treatments to myeloma patients.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close